SEC Tracker
Get the app

Cavitation Technologies CVAT

Cavitation Technologies Q2 FY26: revenue $0; diluted EPS $0.00

Form
10-Q
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers Cavitation Technologies reported for Q2 FY26, the quarter ended Dec 31, 2025, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$0−100% from $76K in Q2 FY2510-Q income statement, on EDGAR
  2. Net income−$476K−182% from $579K in Q2 FY2510-Q income statement, on EDGAR
  3. Diluted EPS$0.00Against $0.00 in Q2 FY2510-Q income statement, on EDGAR
  4. Cash and cash equivalents$31K−95% from $681K in Q2 FY2510-Q balance sheet, on EDGAR
  5. Cash from operations−$182KAgainst −$201K in Q2 FY2510-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Cavitation Technologies files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 700 and related industry codes: the same peer list as the financial tables.

  1. RYTHM RYM public float $27M, Jun 30, 2025
  2. Chase Packaging WHLT public float $4M, Jun 30, 2025
  3. BNB Standard BNC public float $324M, Oct 31, 2025
  4. Mission Produce AVO public float $496M, Apr 30, 2025, over 18 months old
  5. Calavo Growers CVGW public float $500M, Apr 30, 2025, over 18 months old